Darrell J. Elliott
Amministratore Delegato presso Isuma Strategies, Inc.
Profilo
Darrell J.
Elliott currently works at Isuma Strategies, Inc., as President & Co-Chief Executive Officer from 2007, ADERIS Pharmaceuticals, Inc., as Director, IsoTis SA, as Director, Prospiva Capital (VCC), Inc., as Director, Discovery Parks Holdings Ltd., as Director from 2007, and Invivos Partners Ltd., as Director from 2006.
Mr. Elliott also formerly worked at ViRexx Medical Corp., as Chairman & Interim Chief Executive Officer from 2007 to 2008, Calyx Ventures, Inc., as Chairman, President, CEO & CFO, 1322256 Alberta Ltd., as Chairman, Chromos Molecular Systems, Inc., as Chairman, Aztech Innovations, Inc., as Chairman, Nventa Biopharmaceuticals Corp., as Director, SMC Ventures, Inc., as Director, Neuromed Pharmaceuticals, Inc., as Director, IsoTis, Inc., as Director, Arbutus Biopharma Corp., as Director, Auricle Biomedical Corp., as Director from 2007 to 2010, Transformative Ventures Ltd., as Director, Trenchant Capital Corp., as Director, Lumira Capital Investment Management, Inc., as Managing Director from 1999 to 2006, Cognetix, Inc., as Director, Agrisoma Biosciences, Inc., as Director, Neuromed Pharmaceuticals Ltd., as Director, North American Healthcare International, Inc., as Managing Director, Jana Care, Inc., as Director, Canadian Medical Discoveries Fund, Inc., as Vice President, RBC Capital Partners Ltd., as Regional Vice President from 1990 to 1999, and MDS Ventures Pacific, Inc., as President from 1999 to 2006.
Mr. Elliott received his undergraduate degree in 1974 from the University of South Africa.
Posizioni attive di Darrell J. Elliott
| Società | Posizione | Inizio |
|---|---|---|
ADERIS Pharmaceuticals, Inc.
 ADERIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ADERIS Pharmaceuticals, Inc. develops and commercializes drugs and pharmaceuticals. It engages in small molecule drug development to treat central nervous system, cardiovascular, and inflammatory disorders. The company was founded by Donald McAfee, Noel Cusack, Gevork I. Minaskanian, and Peter Savasand in 1994 and is headquartered in Hopkinton, MA. | Direttore/Membro del Consiglio | - |
| Isuma Strategies, Inc. | Amministratore Delegato | 01/10/2007 |
IsoTis SA
 IsoTis SA BiotechnologyHealth Technology IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland. | Direttore/Membro del Consiglio | - |
| Prospiva Capital (VCC), Inc. | Direttore/Membro del Consiglio | 23/11/2009 |
| Discovery Parks Holdings Ltd. | Direttore/Membro del Consiglio | 06/09/2010 |
| Invivos Partners Ltd. | Direttore/Membro del Consiglio | 06/09/2010 |
Precedenti posizioni note di Darrell J. Elliott
| Società | Posizione | Fine |
|---|---|---|
Aztech Innovations, Inc.
 Aztech Innovations, Inc. Electrical ProductsProducer Manufacturing Aztech Innovations, Inc. is engaged in the sale of embedded systems, wireless remote monitoring and demand management products and related services. It was founded on March 7, 2007 and is headquartered in Kingston, Canada. | Presidente | 27/04/2011 |
| Transformative Ventures Ltd. | Direttore/Membro del Consiglio | 22/04/2010 |
Auricle Biomedical Corp.
 Auricle Biomedical Corp. Financial ConglomeratesFinance Auricle Biomedical Corporation is a capital pool company, formed to acquire, through amalgamation, merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more domestic or foreign operating businesses in the healthcare industry. The company proposes to identify and evaluate businesses and assets with a view to completing a qualifying transaction. The company was founded on June 1, 2007 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | 22/04/2010 |
| ░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Darrell J. Elliott
| University of South Africa | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| TRENCHANT TECHNOLOGIES CAPITAL CORP. | Non-Energy Minerals |
| CALYX VENTURES INC. | Technology Services |
| Aziende private | 25 |
|---|---|
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
ADERIS Pharmaceuticals, Inc.
ADERIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ADERIS Pharmaceuticals, Inc. develops and commercializes drugs and pharmaceuticals. It engages in small molecule drug development to treat central nervous system, cardiovascular, and inflammatory disorders. The company was founded by Donald McAfee, Noel Cusack, Gevork I. Minaskanian, and Peter Savasand in 1994 and is headquartered in Hopkinton, MA. | Health Technology |
SMC Ventures, Inc.
 SMC Ventures, Inc. Miscellaneous Commercial ServicesCommercial Services SMC Ventures, Inc. engaged in the provision of management consulting services. The company was founded in 1980 and is headquartered in Vancouver, Canada. | Commercial Services |
1322256 Alberta Ltd.
 1322256 Alberta Ltd. Pharmaceuticals: MajorHealth Technology Inex Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. | Health Technology |
Chromos Molecular Systems, Inc.
 Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology | Health Technology |
ViRexx Medical Corp.
 ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | Health Technology |
Neuromed Pharmaceuticals, Inc.
 Neuromed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals, Inc. develops new and improved pain medicines. It has multiple programs aimed at addressing this important unmet medical need. Its lead product candidate, ExalgoTM is an extended release formulation of hydromorphone in phase 3 clinical development. Neuromed is also developing oral drug candidates to block N-type and T-type calcium channels, an important target directly involved in pain signaling, and includes candidates for potentially treating pain, epilepsy and hypertension. | Health Technology |
IsoTis, Inc.
 IsoTis, Inc. Medical SpecialtiesHealth Technology IsoTis, Inc. designs, manufactures and sells bone graft substitutes and other devices. The company was founded on November 15, 2006 and is headquartered in Plainsboro, NJ. | Health Technology |
Auricle Biomedical Corp.
Auricle Biomedical Corp. Financial ConglomeratesFinance Auricle Biomedical Corporation is a capital pool company, formed to acquire, through amalgamation, merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more domestic or foreign operating businesses in the healthcare industry. The company proposes to identify and evaluate businesses and assets with a view to completing a qualifying transaction. The company was founded on June 1, 2007 and is headquartered in Vancouver, Canada. | Finance |
| Transformative Ventures Ltd. | Finance |
Aztech Innovations, Inc.
Aztech Innovations, Inc. Electrical ProductsProducer Manufacturing Aztech Innovations, Inc. is engaged in the sale of embedded systems, wireless remote monitoring and demand management products and related services. It was founded on March 7, 2007 and is headquartered in Kingston, Canada. | Producer Manufacturing |
| Canadian Medical Discoveries Fund, Inc. | Finance |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Finance |
IsoTis SA
IsoTis SA BiotechnologyHealth Technology IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland. | Health Technology |
RBC Capital Partners Ltd.
 RBC Capital Partners Ltd. Investment ManagersFinance RBC Capital Partners Ltd. is a Venture Capital firm, a subsidiary of RBC Dominion Securities, Inc. founded in 1900. RBC Capital Partners Ltd. is headquartered in Toronto, Canada with offices across the globe. | Finance |
Cognetix, Inc.
 Cognetix, Inc. Drugstore ChainsRetail Trade Cognetix, Inc. discovered and developed drugs. Its products were used for the treatment of epilepsy, local anesthesia, heart disease, stroke, neuromuscular back pain, multiple sclerosis, and spinal cord injury. The company was founded in 1996 by Dennis B. Farrar, Baldomero M. Olivera and J. Michael McIntosh and was headquartered in Salt Lake City, UT | Retail Trade |
Agrisoma Biosciences, Inc.
 Agrisoma Biosciences, Inc. Chemicals: SpecialtyProcess Industries Agrisoma Biosciences, Inc. provides crop technology for biofuel and renewable energy solutions. Its crop improvement technologies include proprietary breeding, proprietary tissue culture and haploidy, molecular markers and genetic mapping and advanced crop improvement technologies. The company was founded by Steven Fabijanski and Tom Mamic in 2001 and is headquartered in Gatineau, Canada. | Process Industries |
Neuromed Pharmaceuticals Ltd.
 Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals Ltd. develops chronic pain drugs. Its NMED-1077 product is an extended release formulation of hydromorphone in phase 3 clinical development. It conducts research for drugs to cure anxiety, epilepsy, hypertension, and cardiovascular diseases. The company was founded by Dr. Terrance P. Snutch in 1998 and is headquartered in Vancouver, BC. | Health Technology |
| MDS Ventures Pacific, Inc. | |
| Isuma Strategies, Inc. | |
North American Healthcare International, Inc.
 North American Healthcare International, Inc. Real Estate DevelopmentFinance North American Healthcare International, Inc. provides healthcare and related professional services. The company is headquartered in Calgary, Canada. | Finance |
| Prospiva Capital (VCC), Inc. | |
| Invivos Partners Ltd. | |
Jana Care, Inc.
 Jana Care, Inc. Packaged SoftwareTechnology Services Jana Care, Inc. develops a mobile diagnostic platform to screen for and monitor chronic diseases. It offers The Aina Device, a self-monitoring device for use by patients at home; and The Aina Station, a point-of-care diagnostic solution for use in clinics and hospitals. The company was founded by Sidhant Jena and Michal Depa in 2011 and is headquartered in Boston, MA. | Technology Services |
| Discovery Parks Holdings Ltd. |
- Borsa valori
- Insiders
- Darrell J. Elliott
